Amid the ongoing COVID-19 public health emergency, the US Food and Drug Administration (FDA) has emphasised the importance of caring for patients with established conditions …

Oncology is one of the most common areas of drug development in the pharmaceutical industry. In 2020, the majority of new drugs approved by the …

International Conference on Harmonization (ICH) guidance makes it feasible to construct a new drug submission dossier that can be used for applications to multiple countries. …

Safety science complexity is on the rise as the volume of safety data explodes (case volumes are growing at a pace of 15 to 20% …

Ensuring Drug Safety, First and Foremost, Even Ahead of Drug Efficacy In the commercialisation of new medications, the paramount legal responsibilities of the pharmaceutical company …

The healthcare industry struggles with resolving fundamental patient communication challenges. Approximately 50% of adults cannot read at a high school level and 88% of adults …

Clinical trials within Asia are on the rise again, however, the effects of the COVID-19 pandemic continue to have a significant impact on the industry. …

Long COVID-19 syndrome has recently been recognised as a complex chronic clinical entity in subjects who have experienced SARS-CoV-2 infection. It is currently defined as …

In light of the proposed shift to value-based healthcare, Gérard Klop and Marcos Gallego Llorente of Vintura set out their vision for how pharma can …

With the number of registered clinical trials increasing significantly each year, it’s not surprising to learn that the clinical trials supply and logistics market is …